Clostridium Difficile vaccine: Phase III started

Sanofi's Sanofi Pasteur S.A. vaccines division began the single-blind, placebo-controlled, international Phase III Cdiffense trial to evaluate its C. difficile vaccine in up to 15,000 adult volunteer...